J2H Biotech. Co., Ltd. announced that it has received KRW 30 billion in Pre-IPO round of funding on July 9, 2021. The company has issued common shares in the transaction. The transaction included participation from IMM Investment Corp., KB Securities Co., Ltd., Company K Partners Limited, E&Investment, Inc., Quad Investment Management Corp., Investment Arm. The company has raised KRW 590 billion in funding till date.